{"SPADE_N_00115": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}, {"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_00115", "Peptide Name": "Acidocin J1132 beta peptide (Bacteriocin)", "Source": "Lactobacillus acidophilus JCM 1132 (Gram-positive bacteria)", "Family": "Belongs to the class IIb bacteriocin", "Gene": "Not found", "Sequence": "GNPKVAHCASQIGRSTAWGAVSGA", "Sequence Length": 24, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q9R499"], "Protein Existence": "Protein level", "Biological Activity": ["Antimicrobial", "Antibacterial"], "Target Organism": "Lactobacillus.", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "Not included yet", "Binding Target": "Not found", "Linear/Cyclic": "Not included yet", "N-terminal Modification": "Not included yet", "C-terminal Modification": "Not included yet", "Stereochemistry": "Not included yet", "Structure Description": "Not found", "Formula": "C98H157N33O31S", "Mass": 2325.56, "PI": 9.51, "Net Charge": 3, "Hydrophobicity": -0.06, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Comments": "Acidocin J1132 is a pore-forming bacteriocin that creates cell membrane channels through the \"barrel-stave\" mechanism. Both alpha and beta had inhibitory activity, and an increase in activity by the complementary action of the two components was observed.", "Literature": [{"Title": "Isolation, partial characterization, and mode of action of Acidocin J1132, a two-component bacteriocin produced by Lactobacillus acidophilus JCM 1132.", "Pubmed ID": "8975617", "Reference": "Appl Environ Microbiol. 1996 Mar;62(3)892-897.", "Author": "Tahara T, Oshimura M, Umezawa C, Kanatani K.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=8975617"}], "Frequent Amino Acids": "AGS", "Absent Amino Acids": "DEFLMOUY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 10, "Polar Residues": 17, "Positive Residues": 3, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_04115", "Similarity": 1.0, "Sequence": "MEKLMVLNEEKLSYVIGGGNPKVAHCASQIGRSTAWGAVSGAATGTAVGQAVGALGGALFGGSMGVIKGSAACVSYLTRHRHH"}, {"SPADE_ID": "SPADE_N_00114", "Similarity": 1.0, "Sequence": "NPKVAHCASQIGRSTAWGAVSGA"}]}}}